porphobilinogen has been researched along with Genetic Predisposition in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Senn, JD | 1 |
| Huber, LC | 1 |
| Barman-Aksözen, J | 1 |
| Minder, E | 1 |
| Barreda-Sánchez, M | 1 |
| Buendía-Martínez, J | 1 |
| Glover-López, G | 1 |
| Carazo-Díaz, C | 1 |
| Ballesta-Martínez, MJ | 1 |
| López-González, V | 1 |
| Sánchez-Soler, MJ | 1 |
| Rodriguez-Peña, L | 1 |
| Serrano-Antón, AT | 1 |
| Gil-Ferrer, R | 1 |
| Martínez-Romero, MDC | 1 |
| Carbonell-Meseguer, P | 1 |
| Guillén-Navarro, E | 1 |
| Billoo, AG | 1 |
| Lone, SW | 1 |
| Paradisi, I | 1 |
| Arias, S | 1 |
| Kuo, HC | 1 |
| Lee, MJ | 1 |
| Chuang, WL | 1 |
| Huang, CC | 1 |
1 review available for porphobilinogen and Genetic Predisposition
| Article | Year |
|---|---|
[CME: Acute Intermittent Porphyria: When to Think of It? What Must be Checked? How to Treat?]
Topics: Arginine; Combined Modality Therapy; Diagnosis, Differential; Female; Genetic Predisposition to Dise | 2018 |
4 other studies available for porphobilinogen and Genetic Predisposition
| Article | Year |
|---|---|
High penetrance of acute intermittent porphyria in a Spanish founder mutation population and CYP2D6 genotype as a susceptibility factor.
Topics: Adolescent; Adult; Aged; Creatinine; Cytochrome P-450 CYP2D6; Female; Genetic Predisposition to Dise | 2019 |
A family with acute intermittent porphyria.
Topics: Adolescent; Aminolevulinic Acid; Family; Female; Genetic Predisposition to Disease; Humans; Pedigree | 2008 |
Marked geographic aggregation of acute intermittent porphyria families carrying mutation Q180X in Venezuelan populations, with description of further mutations.
Topics: Adolescent; Adult; Biomarkers; Child; Child, Preschool; DNA Mutational Analysis; Female; Founder Eff | 2010 |
Acute intermittent porphyria with peripheral neuropathy: a follow-up study after hematin treatment.
Topics: Adult; Aminolevulinic Acid; DNA Mutational Analysis; Female; Follow-Up Studies; Genetic Markers; Gen | 2007 |